Article info
PDFValvular heart disease
Original research article
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
- Correspondence to Dr Derk Frank, Department of Cardiology and Angiology, University Hospital Schleswig-Holstein, Campus Kiel Arnold-Heller-Str. 3, Haus 6, 24105 Kiel, Germany; derk.frank{at}uksh.de
Citation
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
Publication history
- Received March 28, 2017
- Revision received April 12, 2017
- Accepted April 25, 2017
- First published June 10, 2017.
Online issue publication
April 30, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/